Thus, we speculated that reduced expression of miR-744 in cancer cell-derived EVs enhanced SUV39H1, which further suppressed the expression of Smad9 and consequently elevated the BMP4 expression, promoting the NSCLC progression. Here, SUV39H1 is linked to cancer.